(P-1229) Characterization of Ampicillin (AMP) and Vancomycin (VAN) Pharmacokinetics-Pharmacodynamics (PK-PD) in a Neutropenic Murine Invasive Enterococcal Infection Model

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Brian D. VanScoy, B.S.

Director
Institute for Clinical Pharmacodynamics
Schenectady, NY, United States

AS

Allison N. Seyfried, M.S.

Institute for Clinical Pharmacodynamics, Inc.
Schenectady, New York, United States
AM

Alexander S. MacGregor, B.S.

Institute for Clinical Pharmacodynamics, Inc.
Schenectady, New York, United States
MN

Micah Nasman, B.S.

Institute for Clinical Pharmacodynamics, Inc.
-- Select one --, New York, United States
CR

Christopher M. Rubino, PharmD

Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Rodrigo E. Mendes, PhD (he/him/his)

Director
Element Iowa City (JMI Laboratories)
North Liberty, IA, United States
HS

Helio Sader
PA

Paul G. Ambrose, PharmD; MS; FIDSA

President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Sujata M. Bhavnani, PharmD; MS; FIDSA

Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States